These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6194132)

  • 1. The role of substance P in the nigrostriatal system.
    Borison RL; Klawans HL; Diamond BI
    Int J Neurol; 1980; 14(2-4):189-94. PubMed ID: 6194132
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of nigrostriatal synaptic circuitry, striatal mRNA expression, and motor symmetry following embryonic substantia nigra grafts.
    Mendez I; Elisevich K; Naus C; Flumerfelt B
    Clin Neurosurg; 1992; 38():180-209. PubMed ID: 1371434
    [No Abstract]   [Full Text] [Related]  

  • 3. One-trial conditioned rotation in rats.
    Silverman PB
    NIDA Res Monogr; 1989; 95():540-1. PubMed ID: 2577050
    [No Abstract]   [Full Text] [Related]  

  • 4. 3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway.
    Reches A; Mielke LR; Fahn S
    Neurology; 1982 Aug; 32(8):887-8. PubMed ID: 7201586
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum.
    Micheletti G; Lannes B; Warter JM; Zwiller J
    Adv Neurol; 1993; 60():128-32. PubMed ID: 8380517
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 9. Tachykinins and related peptides in the substantia nigra and neostriatum.
    Hökfelt T; Reid M; Herrera-Marschitz M; Ungerstedt U; Terenius L; Håkanson R; Feng DM; Folkers K
    Ann N Y Acad Sci; 1991; 632():192-7. PubMed ID: 1719865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
    Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
    Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible mechanisms involved in the stereotyped behavior elicited by amphetamine.
    Groves PM
    Biol Psychiatry; 1977 Jun; 12(3):381-8. PubMed ID: 194632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
    Melamed E
    Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents.
    Fornai F; Bassi L; Bonaccorsi I; Giorgi F; Corsini GU
    Funct Neurol; 1997; 12(3-4):193-8. PubMed ID: 9218976
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
    Tan DP; Tsou K
    Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
    Oberlander C; Euvrard C; Dumont C; Boissier JR
    Eur J Pharmacol; 1979 Dec; 60(2-3):163-70. PubMed ID: 575095
    [No Abstract]   [Full Text] [Related]  

  • 19. Short term augmentation of amphetamine-induced rotation bias.
    Elias JW; Yandell LR; Graff R; Albrecht JW; Smith CJ
    Physiol Behav; 1983 Nov; 31(5):639-42. PubMed ID: 6686683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
    Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.